Vital Signs: Carbapenem-Resistant Enterobacteriaceae
March 5, 2013 | Report
Carbapenem-resistant Enterobacteriaceae are recognized in health care settings as a cause of difficut to treat infections associated with high mortality.
You are now viewing 1 - 10 of 47 results
March 5, 2013 | Report
Carbapenem-resistant Enterobacteriaceae are recognized in health care settings as a cause of difficut to treat infections associated with high mortality.
January 30, 2013 | Grantee/Infographic
Working to reduce drug-resistant infections by recognizing that antibiotics are a natural resource and developing new solutions.
February 28, 2013 | Journal Article
Seasonal and age variations seen in hospital MRSA infection rates.
April 2, 2013 | Pioneering Ideas Blog Post
Dr. Daniel J. Morgan, a physician and researcher for Extending the Cure, tells us what it’s like to face superbugs in the health care system and points out the critical role that hospitals can, and should, play in the effort to stop them.
January 28, 2013 | Pioneering Ideas Blog Post
Beth Toner, RN explains how antibiotics don’t fight infections that are caused by viruses, including influenza.
July 1, 2012 | Journal Article
This study investigates the seasonal relationship between drug-resistant bacteria (E. coli and methicillin-resistant Staphylococcus aureus or MRSA) and antibiotic prescription levels in the United States from 1999–2007.
February 1, 2011 | Issue Brief
In this new policy brief, Extending the Cure (ETC) summarizes the latest research about the effectiveness of interventions aimed at reducing doctor's over-prescribing of antibiotics.
November 15, 2012 | Pioneering Ideas Blog Post
Grantee Ramanan Laxminarayan discusses antibiotic resistance.
March 3, 2011 | Report
The rapid rise of antibiotic resistance can be tracked using ResistanceMap, an online tool that visually highlights regions of the country where this growing public health threat is particularly severe.
January 1, 2012 | Journal Article
When patients are likely to develop immunity to infection, the duration of antibiotic treatments can be shortened without harm, thus delaying the spread of drug resistance and its concomitant public health impacts, according to this model-based analysis.